Consists of Clindamycin Topical, Nicotinamide
|
||
Clindamycin Topical/Nicotinamide Pregnancy |
||
Consists of Clindamycin Topical, Nicotinamide
This drug should be used during pregnancy only if clearly needed. AU TGA pregnancy category: A US FDA pregnancy category: B
Animal studies have failed to reveal evidence of fetal harm when given oral or parenteral doses up to 300 mg/kg/day. Approximately 1.1% of pregnant patients in their second trimester given the vaginal cream experienced abnormal labor, compared to 0.5% of patients given placebo. There are no controlled data in the first trimester of human pregnancy. AU TGA pregnancy category A: Drugs which have been taken by a large number of pregnant women and women of childbearing age without any proven increase in the frequency of malformations or other direct or indirect harmful effects on the fetus having been observed. US FDA pregnancy category B: Animal reproduction studies have failed to demonstrate a risk to the fetus and there are no adequate and well-controlled studies in pregnant women.
See references
This drug is excreted into breastmilk when given orally or intravenously.
Use is not recommended and a decision should be made to discontinue breastfeeding or discontinue the drug, taking into account the importance of the drug to the mother. Excreted into human milk: Unknown Excreted into animal milk: Unknown Comment: The effects in the nursing infant are unknown.
See references
Category A: Controlled studies in women fail to demonstrate a risk to the foetus in the 1st trimester (and there is no evidence of a risk in later trimesters), and the possibility of foetal harm remains remote.
There are no reviews yet. Be the first to write one! |
Information checked by Dr. Sachin Kumar, MD Pharmacology
|